ISB-2001

N/A

Report date: 2026/04/03 20:03:44
First In Class

Base Information

Drug NameISB-2001
Drug Alias NameISB-2001ABBV-2001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Trispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionAnti-BCMAAnti-CD38CD3 T-cell engagers
TargetsB-cell maturation proteinLymphocyte differentiation antigen CD38T cell surface glycoprotein CD3
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNorwayItaly +[7] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIchnos Sciences Sa
China Registration ClassN/A

Develop Information

Active CompaniesIchnos Sciences SaIchnos Glenmark Innovation IncAbbvie Inc
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A